tm
Seeing Is Believing
tm
Seeing Is Believing
APRE is currently covered by 1 analysts with an average potential upside of $29.57 (28.89%) from yesterday's end of day stock price of $3.64. Aprea Therapeutics activity chart has currently 7 price targets and 8 ratings on display.
Analysts average stock forecasts to be materialized ratio is 62.5% with an average time for these price targets to be met of 19 days.
Highest price target for APRE is $40, Lowest price target is $40, average price target is $40.
Most recent stock forecast was given by GREGORY RENZA from RBC on 16-Mar-2022. First documented stock forecast 29-Sep-2020.
Currently, out of the existing stock ratings of APRE - 1 which are a Hold (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
80
$76.36 (2097.80%)
1 years 8 months 18 days ago
0/2 (0%)
$60.8 (84.82%)
Sell
500
2 years 3 months 14 days ago
1/1 (100%)
$47.6 (10.52%)
2
Sell
60
$56.36 (1548.35%)
100
2 years 3 months 22 days ago
3/3 (100%)
$4 (3.03%)
72
Hold
5
$4.34 (657.58%)
45
2 years 11 months 5 days ago
1/2 (50%)
$5.86 (17.20%)
2
What is APRE (Aprea Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?
Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?
Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?
Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?
